tradingkey.logo

UK's Oxford Nanopore gains as CEO reportedly flags takeover exposure

ReutersMar 21, 2025 1:36 PM

Biotech group Oxford Nanopore Technologies ONT.L up as much as 5.7% at 115.9p

Gene sequencing specialist is now "exposed" to acquisition, CEO and co-founder Gordon Sanghera told FT

ONT's shares have lost 85% since its peak in 2021

"Bankers have said it could be attractive to one of the big diagnostics specialists, such as Thermo Fisher Scientific TMO.N or Danaher DHR.N," FT report adds

As of last close, stock down ~15% this year

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI